Submit Deal

CUREVAC

Summary

CureVac is a biopharmaceutical company headquartered in Tübingen, Germany, that develops therapies based on messenger RNA.

Deals Overview

Total Deals3

Valued Deals3

Total Value£ 797 M

Avg. Deal Size£ 266 M

Market Context

Senior Management

Sort

Target: CUREVAC

Bidder: FEDERAL REPUBLIC OF GERMANY

3 Service Providers

6 Dealmakers

£ 266 M

Value

Target: CUREVAC

Bidder: KFW GROUP

10 Service Providers

89 Dealmakers

£ 503 M

Value

Target: FRAME CANCER THERAPEUTICS

Bidder: CUREVAC

4 Service Providers

27 Dealmakers

£ 27 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy